# Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

> **NCT01209949** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 30 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene 0.1% and Benzoyl Peroxide 2.5% gel

## Key facts

- **NCT ID:** NCT01209949
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209949, "Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01209949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*